Opportunity Information: Apply for RFA CA 09 013

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Cancer Nanotechnology Platform Partnerships (U01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control.
  • This funding opportunity was created on May 29, 2009 and posted on May 28, 2009.
  • Applicants must submit their applications by Oct 14, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $400,000.00 in funding.
  • Eligible applicants include: Private institutions of higher education For profit organizations other than small businesses County governments State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses City or township governments.
  • Other Eligible Applicants include the following Eligible Agencies of the Federal Government Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations U.S. Territory or Possession.
Apply for RFA CA 09 013

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Cancer Nanotechnology Platform Partnerships (CNPPs) (U01) funding opportunity (RFA-CA-09-013) is a National Cancer Institute (NCI), NIH cooperative agreement program meant to push forward cancer-focused nanotechnology platforms that can unlock new capabilities in basic and preclinical cancer research. The core idea is to support well-defined, “circumscribed” projects that use innovative nanotechnology approaches to tackle major barriers or fundamental questions tied to cancer biology, detection and diagnosis, prevention, or treatment. Rather than funding isolated projects, the FOA is built around multidisciplinary, team-based research where investigators can combine expertise across fields like engineering, materials science, chemistry, physics, biology, and oncology to produce transformative advances that would be difficult to achieve in a single-discipline setting.

CNPPs sit inside a larger NCI program called the NCI Alliance for Nanotechnology in Cancer (the Alliance). In that broader ecosystem, the Centers of Cancer Nanotechnology Excellence (CCNEs) function as a central infrastructure component, and the Alliance also includes two training programs. The CNPP mechanism is intended to benefit from this networked structure, with applicants encouraged to leverage the collaborative environment of the Alliance to accelerate platform development, share knowledge, and improve the odds that promising technologies can move from concept to robust preclinical proof-of-concept. A key message of the announcement is that these are “platform” projects, meaning they are expected to build or mature enabling nanotechnology capabilities that can be applied to cancer research problems, not just produce one-off experiments.

This FOA uses the U01 cooperative agreement mechanism, which typically signals substantial scientific and/or programmatic involvement by NIH staff compared with a standard grant. In practical terms, awardees should expect more active coordination with the funding institute and a stronger emphasis on collaboration, milestones, and alignment with program goals. The opportunity is categorized as discretionary funding and falls under health and education-related activity areas, with relevance across multiple CFDA listings spanning cancer cause and prevention, detection and diagnosis, treatment, biology, and control.

Eligibility is broad and includes public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses and other for-profits), and state, county, city/township governments. The FOA also notes additional eligible applicants such as federal government agencies, non-U.S. (foreign) entities, regional organizations, and U.S. territories or possessions, indicating an intent to cast a wide net for strong platform concepts and capable teams. The announcement also emphasizes that participation is open to all qualified applicants, whether or not they were involved in earlier versions of the Alliance program.

Administratively, the FOA was posted in late May 2009, with an original and current closing date of October 14, 2009, and an archive date of November 14, 2009. The listed award ceiling is $400,000, and there is no cost sharing or matching requirement, which lowers barriers to participation for institutions that may not have discretionary funds to meet a match. The sponsoring agency is NIH (specifically NCI), and applicants were directed to the NIH grants guidance page for the full text of the RFA, with support contacts provided through the NIH Office of Extramural Research webmaster for access or linking issues.

FAQs: Cancer Nanotechnology Platform Partnerships (CNPPs) (U01) - RFA-CA-09-013

What is the Cancer Nanotechnology Platform Partnerships (CNPPs) funding opportunity?

The Cancer Nanotechnology Platform Partnerships (CNPPs) (U01) opportunity (RFA-CA-09-013) is a National Cancer Institute (NCI), NIH cooperative agreement program designed to advance cancer-focused nanotechnology platforms. The purpose is to unlock new capabilities for basic and preclinical cancer research through well-defined projects that apply innovative nanotechnology approaches to major barriers or fundamental questions in cancer.

What does CNPPs aim to accomplish?

CNPPs aims to support "circumscribed" projects that build or mature enabling nanotechnology capabilities (platforms) that can be applied to cancer research problems. The expectation is that these platforms will help address challenges tied to cancer biology, detection and diagnosis, prevention, or treatment, and help move promising technologies toward robust preclinical proof-of-concept.

What types of research areas are relevant to this FOA?

The FOA describes relevance across cancer biology, detection and diagnosis, prevention, and treatment, with a focus on basic and preclinical cancer research. It also notes broader relevance across multiple cancer-related activity areas spanning cause and prevention, detection and diagnosis, treatment, biology, and control.

What is meant by a "platform" project in this announcement?

In this FOA, a "platform" project is expected to create or advance enabling nanotechnology capabilities that can be used across cancer research problems, rather than producing only one-off experiments. The emphasis is on building something that expands what researchers can do in basic and preclinical cancer research.

Why does the FOA emphasize team-based, multidisciplinary research?

The FOA is built around multidisciplinary, team-based research because transformative advances in nanotechnology-enabled cancer research often require combining expertise across fields such as engineering, materials science, chemistry, physics, biology, and oncology. The program is intended to support work that would be difficult to accomplish within a single discipline.

How is CNPPs connected to the NCI Alliance for Nanotechnology in Cancer?

CNPPs is part of the larger NCI Alliance for Nanotechnology in Cancer (the Alliance). Within that broader program, the Centers of Cancer Nanotechnology Excellence (CCNEs) serve as a central infrastructure component, and the Alliance also includes two training programs. CNPP applicants are encouraged to leverage the collaborative environment of the Alliance to accelerate platform development and share knowledge.

Do applicants need to be part of the Alliance already to apply?

No. The announcement emphasizes that participation is open to all qualified applicants, whether or not they were involved in earlier versions of the Alliance program.

What grant mechanism is used, and what does it imply?

This FOA uses the U01 cooperative agreement mechanism. This typically indicates substantial scientific and/or programmatic involvement by NIH staff compared with a standard grant. In practical terms, awardees should expect more active coordination with the funding institute and a stronger emphasis on collaboration, milestones, and alignment with program goals.

Who is the sponsoring agency for this opportunity?

The sponsoring agency is the National Institutes of Health (NIH), specifically the National Cancer Institute (NCI).

What is the maximum award amount listed for this opportunity?

The listed award ceiling is $400,000.

Is cost sharing or matching required?

No. The FOA states there is no cost sharing or matching requirement.

What types of organizations are eligible to apply?

Eligibility is broad and includes public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including both 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses and other for-profits), and state, county, and city/township governments.

Are federal agencies or non-U.S. organizations eligible?

Yes. The FOA notes additional eligible applicants such as federal government agencies, non-U.S. (foreign) entities, regional organizations, and U.S. territories or possessions.

What is the funding category and general activity area?

The opportunity is categorized as discretionary funding and falls under health and education-related activity areas, with relevance across multiple cancer-related CFDA listings.

When was the FOA posted, and what are the key dates?

The FOA was posted in late May 2009. The original and current closing date is October 14, 2009. The archive date is November 14, 2009.

Where can applicants find the full text of the RFA?

Applicants were directed to the NIH grants guidance page for the full text of the RFA.

Who should be contacted for access or linking issues related to the announcement?

The FOA indicates that support contacts were provided through the NIH Office of Extramural Research webmaster for access or linking issues.

Browse more business programs for Technology Service Providers, Nanotechnology Companies

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: FY 2009 American Recovery and Reinvestment Act Fire Station Construction Grant Program

Previous opportunity: Centers of Cancer Nanotechnology Excellence (CCNEs)(U54)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 09 013

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 09 013) also looked into and applied for these:

Funding Opportunity
Biomarkers for Early Detection of Hematopoietic Malignancies (R01) Apply for PA 09 197

Funding Number: PA 09 197
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Biomarkers for Early Detection of Hematopoietic Malignancies (R21) Apply for PA 09 198

Funding Number: PA 09 198
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Identifying Non coding RNA Targets for Cancer Early Detection and Prevention (R21) Apply for PA 09 200

Funding Number: PA 09 200
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Identifying Non coding RNA Targets for Cancer Early Detection and Prevention (R01) Apply for PA 09 199

Funding Number: PA 09 199
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The National Drug Abuse Treatment Clinical Trials Network (U10) Apply for RFA DA 10 009

Funding Number: RFA DA 10 009
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Bioenergetics, Fatigability, and Activity Limitations in Aging (R21) Apply for PA 09 191

Funding Number: PA 09 191
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
Bioenergetics, Fatigability, and Activity Limitations in Aging (R01) Apply for PA 09 190

Funding Number: PA 09 190
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) Apply for PAR 09 162

Funding Number: PAR 09 162
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Feasibility Studies for Collaborative Interaction for Minority Institution/Cancer Center Partnership (P20) Apply for PAR 09 201

Funding Number: PAR 09 201
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $275,000
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (F31) Apply for PA 09 208

Funding Number: PA 09 208
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Cutting Edge Basic Research Awards (CEBRA) (R21) Apply for PAR 09 222

Funding Number: PAR 09 222
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $125,000
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01) Apply for RFA CA 09 025

Funding Number: RFA CA 09 025
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The Early Detection Research Network Biomarker Developmental Laboratories (U01) Apply for RFA CA 09 017

Funding Number: RFA CA 09 017
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $400,000
Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows in Nursing Research (F31) Apply for PAR 09 227

Funding Number: PAR 09 227
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Mechanisms Underlying the Links between Psychosocial Stress, Aging, the Brain and the Body (R01) Apply for PA 09 216

Funding Number: PA 09 216
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Diet, Epigenetic Events, and Cancer Prevention (R01) Apply for PA 09 234

Funding Number: PA 09 234
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Diet, Epigenetic Events, and Cancer Prevention (R21) Apply for PA 09 235

Funding Number: PA 09 235
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000
HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01) Apply for PA 09 236

Funding Number: PA 09 236
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R21) Apply for PA 09 237

Funding Number: PA 09 237
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis (R21) Apply for PA 09 238

Funding Number: PA 09 238
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 09 013", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.